Covestor’s Beta Bionics BBNX Stock Holding History

Covestor’s Portfolio BBNX Stock Details BBNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$0	Sell	15 -11	-42%	-$198	﹤0.01%	2940
2026 Q2	$0	Buy	26 +19	+271%	+$226	﹤0.01%	2907
2026 Q1	$0	Buy	+7	New	+$104	﹤0.01%	2883

Other funds holding BBNX

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Values First Advisors Gray, Tennessee $213M AUM 20.51% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Covestor's BBNX Position: Q3 2026 in Review

Covestor reduced its Beta Bionics (BBNX) stake by 42% in Q3 2026, selling an estimated $198 and leaving 15 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2940.

Covestor first reported a position in BBNX in Q1 2026 and has held it in 3 quarters since. 46 funds tracked by Wall St. Rank hold BBNX as of Q3 2026.

Covestor held 15 shares of Beta Bionics worth $0 as of Q3 2026.
Covestor sold 11 Beta Bionics shares in Q3 2026, an estimated $198.
Beta Bionics made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2940 holding.
Covestor first reported a position in Beta Bionics in Q1 2026 and has held it in 3 quarters since.
46 funds tracked by Wall St. Rank held Beta Bionics as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.